Phase II Study of Perioperative Chemotherapy with Cisplatin and Pemetrexed in Non–Small-Cell Lung Cancer-Reference-Cited by-同舟云学术

Phase II Study of Perioperative Chemotherapy with Cisplatin and Pemetrexed in Non–Small-Cell Lung Cancer

Published:2014-02 Issue:2 Volume:9 Page:222-230
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Dy Grace K.,Bogner Paul N.,Tan Wei,Demmy Todd L.,Farooq Aamer,Chen Hongbin,Yendamuri Saikrishna S.,Nwogu Chukwumere E.,Bushunow Peter W.,Gannon James,Adjei Araba A.,Adjei Alex A.,Ramnath Nithya

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference40 articles.

1. Cancer statistics, 2013;Siegel;CA Cancer J Clin,2012

2. Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II, and IIIa non-small-cell lung cancer;Depierre;J Clin Oncol,2002

3. Preresectional chemotherapy in stage IIIA non-small-cell lung cancer: a 7-year assessment of a randomized controlled trial;Rosell;Lung Cancer,1999

4. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer;Roth;J Natl Cancer Inst,1994

5. Combined radiotherapy and resection for carcinoma of the bronchus; experiences with 66 patients;Bromley;Lancet,1955

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neoadjuvant Chemoimmunotherapy for NSCLC;JAMA Oncology;2024-05-01

2. SLC19A1 and Thymidylate Synthase Polymorphisms Do not Predict Survival Outcome in Non-Small-Cell Lung Cancer Treated with Pemetrexed-Cisplatin Chemotherapy Regimen;MIDDLE EAST J CANCER;2023

3. SLC19A1 and Thymidylate Synthase Polymorphisms Do not Predict Survival Outcome in Non-Small-Cell Lung Cancer Treated with Pemetrexed-Cisplatin Chemotherapy Regimen;MIDDLE EAST J CANCER;2023

4. Pathological complete response to neoadjuvant chemoimmunotherapy correlates with peripheral blood immune cell subsets and metastatic status of mediastinal lymph nodes (N2 lymph nodes) in non-small cell lung cancer;Lung Cancer;2022-10

5. Neoadjuvant immunotherapy and neoadjuvant chemotherapy in resectable non-small cell lung cancer: A systematic review and single-arm meta-analysis;Frontiers in Oncology;2022-09-21